VAD Trials & Outcomes
HeartMate II Clinical Results The New Era Begins.
The HeartMate II® trial was the fastest-enrolling VAD trial in the field of mechanical circulatory support. 85% of patients in the bridge-to-transplantation arm of the trial demonstrated improvement from NYHA Class IV to NYHA Class I or II.
HARPS Trial Now Enrolling
The Harefield Recovery Protocol (HARPS) is currently evaluating if advanced heart failure patients with VAD support can recover sufficient myocardial function to allow device removal (explantation).
Recovery post-VAD
Two years after receiving a VAD, Salina Gonzales, of San Antonio is enjoying a full life without it.